8-K/A XBRL

CURRENT REPORT

Company: Sonoma Pharmaceuticals, Inc.
Filed: October 11, 2023
Period of Report: October 11, 2023
Accession Number: 0001683168-23-007057

View Document ↗ View on SEC.gov ↗